Le Qu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Renal and related cancers
- RNA Research and Splicing
Papers in
-
- Cancer-related molecular mechanisms research 9
- Cancer Genomics and Diagnostics 8
- MicroRNA in disease regulation 4
-
- Renal cell carcinoma treatment 24
- Ferroptosis and cancer prognosis 13
Le Qu
52 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 89
- Cancer Research 644
- Molecular Biology 884
- Pulmonary and Respiratory Medicine 415
- Dermatology 108
- Oncology 234
Countries citing papers authored by Le Qu
This map shows the geographic impact of Le Qu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Le Qu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Le Qu more than expected).
Fields of papers citing papers by Le Qu
This network shows the impact of papers produced by Le Qu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Le Qu. The network helps show where Le Qu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Le Qu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 9 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 6 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 0 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 23 | |
| 15 | 2022 | 38 | |
| 16 | 2017 | 104 | |
| 17 | 2015 | 4 | |
| 18 | 2014 | 97 | |
| 19 | 2012 | 114 | |
| 20 | Development of ERCC RNA Spike-In Control Mixes | 2011 | 9 |
About Le Qu
Le Qu is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Health Informatics, Oncology and Molecular Biology, having authored 61 papers that have together received 1.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (24 papers), Ferroptosis and cancer prognosis (13 papers), Renal and related cancers (10 papers), Cancer-related molecular mechanisms research (9 papers), Cancer Genomics and Diagnostics (8 papers), Epigenetics and DNA Methylation (7 papers), Circular RNAs in diseases (5 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (644 citations), Molecular Biology (884 citations), Pulmonary and Respiratory Medicine (415 citations), Dermatology (108 citations) and Oncology (234 citations). Le Qu has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Zhenjie Wu, Yi Bao, Linhui Wang, Bing Liu, Linhui Wang, Deng-Shuang Wu, Anbang Wang, Jiazi Shi, Cheng Chen and Jiayi Liu. Their work appears in journals such as Frontiers in Immunology, Frontiers in Oncology, Cancer Biology & Therapy, Oxidative Medicine and Cellular Longevity and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.